Compliance with Guidelines on Thromboprophylaxis for Acutely Admitted Medical Patients

Introduction The risk of venous thromboembolism (VTE) is increased by more than 100-fold among hospitalised medical patients compared to subjects in the community. The Danish Council for the Use of Expensive Hospital Medicines has published national guidelines on thromboprophylaxis (TP) in which the...

Full description

Saved in:
Bibliographic Details
Published inAdvances in therapy Vol. 35; no. 11; pp. 1873 - 1883
Main Authors Freund, Nanna, Sabroe, Jonas E., Bytzer, Peter, Madsen, Søren M.
Format Journal Article
LanguageEnglish
Published Cheshire Springer Healthcare 01.11.2018
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Introduction The risk of venous thromboembolism (VTE) is increased by more than 100-fold among hospitalised medical patients compared to subjects in the community. The Danish Council for the Use of Expensive Hospital Medicines has published national guidelines on thromboprophylaxis (TP) in which the risks of VTE and bleeding are balanced. We wanted to investigate the proportion of acutely admitted medical patients for whom thromboprophylaxis was indicated and to what extent the guidelines were followed. Methods Data from patients hospitalised at two medical wards were screened. We registered the proportion of patients for whom mechanical or pharmacologic TP (MTP and PTP, respectively) was indicated and whether national guidelines were followed. All data extraction and analyses were performed retrospectively. Results After exclusion criteria were applied, 340 cases remained. PTP was indicated in 26 patients (7.6%) but only 4 patients were treated besides 12 patients who were already in anticoagulant treatment at submission. Conversely, 8/306 patients, in whom TP was not indicated, were started on PTP. MTP was indicated in 8/340 patients (2.4%) but therapy was not initiated in any of them. The majority (320/340, 94.1%) of cases was managed in accordance with existing guidelines. However, this high proportion was mainly explained by the large number of untreated patients, where TP was not indicated. Conclusion A large proportion of hospitalised medical patients was managed in conflict with national guidelines. A systematic approach to TP in patients with acute medical illness should be implemented. Plain Language Summary Plain language summary available for this article.
AbstractList Introduction The risk of venous thromboembolism (VTE) is increased by more than 100-fold among hospitalised medical patients compared to subjects in the community. The Danish Council for the Use of Expensive Hospital Medicines has published national guidelines on thromboprophylaxis (TP) in which the risks of VTE and bleeding are balanced. We wanted to investigate the proportion of acutely admitted medical patients for whom thromboprophylaxis was indicated and to what extent the guidelines were followed. Methods Data from patients hospitalised at two medical wards were screened. We registered the proportion of patients for whom mechanical or pharmacologic TP (MTP and PTP, respectively) was indicated and whether national guidelines were followed. All data extraction and analyses were performed retrospectively. Results After exclusion criteria were applied, 340 cases remained. PTP was indicated in 26 patients (7.6%) but only 4 patients were treated besides 12 patients who were already in anticoagulant treatment at submission. Conversely, 8/306 patients, in whom TP was not indicated, were started on PTP. MTP was indicated in 8/340 patients (2.4%) but therapy was not initiated in any of them. The majority (320/340, 94.1%) of cases was managed in accordance with existing guidelines. However, this high proportion was mainly explained by the large number of untreated patients, where TP was not indicated. Conclusion A large proportion of hospitalised medical patients was managed in conflict with national guidelines. A systematic approach to TP in patients with acute medical illness should be implemented. Plain Language Summary Plain language summary available for this article.
INTRODUCTIONThe risk of venous thromboembolism (VTE) is increased by more than 100-fold among hospitalised medical patients compared to subjects in the community. The Danish Council for the Use of Expensive Hospital Medicines has published national guidelines on thromboprophylaxis (TP) in which the risks of VTE and bleeding are balanced. We wanted to investigate the proportion of acutely admitted medical patients for whom thromboprophylaxis was indicated and to what extent the guidelines were followed.METHODSData from patients hospitalised at two medical wards were screened. We registered the proportion of patients for whom mechanical or pharmacologic TP (MTP and PTP, respectively) was indicated and whether national guidelines were followed. All data extraction and analyses were performed retrospectively.RESULTSAfter exclusion criteria were applied, 340 cases remained. PTP was indicated in 26 patients (7.6%) but only 4 patients were treated besides 12 patients who were already in anticoagulant treatment at submission. Conversely, 8/306 patients, in whom TP was not indicated, were started on PTP. MTP was indicated in 8/340 patients (2.4%) but therapy was not initiated in any of them. The majority (320/340, 94.1%) of cases was managed in accordance with existing guidelines. However, this high proportion was mainly explained by the large number of untreated patients, where TP was not indicated.CONCLUSIONA large proportion of hospitalised medical patients was managed in conflict with national guidelines. A systematic approach to TP in patients with acute medical illness should be implemented. Plain language summary available for this article.
The risk of venous thromboembolism (VTE) is increased by more than 100-fold among hospitalised medical patients compared to subjects in the community. The Danish Council for the Use of Expensive Hospital Medicines has published national guidelines on thromboprophylaxis (TP) in which the risks of VTE and bleeding are balanced. We wanted to investigate the proportion of acutely admitted medical patients for whom thromboprophylaxis was indicated and to what extent the guidelines were followed. Data from patients hospitalised at two medical wards were screened. We registered the proportion of patients for whom mechanical or pharmacologic TP (MTP and PTP, respectively) was indicated and whether national guidelines were followed. All data extraction and analyses were performed retrospectively. After exclusion criteria were applied, 340 cases remained. PTP was indicated in 26 patients (7.6%) but only 4 patients were treated besides 12 patients who were already in anticoagulant treatment at submission. Conversely, 8/306 patients, in whom TP was not indicated, were started on PTP. MTP was indicated in 8/340 patients (2.4%) but therapy was not initiated in any of them. The majority (320/340, 94.1%) of cases was managed in accordance with existing guidelines. However, this high proportion was mainly explained by the large number of untreated patients, where TP was not indicated. A large proportion of hospitalised medical patients was managed in conflict with national guidelines. A systematic approach to TP in patients with acute medical illness should be implemented. Plain language summary available for this article.
Author Madsen, Søren M.
Freund, Nanna
Sabroe, Jonas E.
Bytzer, Peter
Author_xml – sequence: 1
  givenname: Nanna
  orcidid: 0000-0001-8407-6894
  surname: Freund
  fullname: Freund, Nanna
  email: nannafreund@gmail.com
  organization: Department of Medicine, Zealand University Hospital Køge
– sequence: 2
  givenname: Jonas E.
  surname: Sabroe
  fullname: Sabroe, Jonas E.
  organization: Department of Medicine, Zealand University Hospital Køge
– sequence: 3
  givenname: Peter
  surname: Bytzer
  fullname: Bytzer, Peter
  email: pmby@regionsjaelland.dk
  organization: Department of Medicine, Zealand University Hospital Køge, Department of Clinical Medicine, University of Copenhagen
– sequence: 4
  givenname: Søren M.
  surname: Madsen
  fullname: Madsen, Søren M.
  email: smma@regionsjaelland.dk
  organization: Department of Medicine, Zealand University Hospital Køge
BackLink https://www.ncbi.nlm.nih.gov/pubmed/30367365$$D View this record in MEDLINE/PubMed
BookMark eNp9kL1OxDAQhC0EguPgAWiQS5qA1_lxXJ5OcCCBoABEZznJhjNK7MNOBHl7jA4oKVZb7Mxo5zsku9ZZJOQE2DkwJi4C8JTnCYMyYSWHZNohMyiLPInDd8mMiQwSnpYvB-QwhDfGOBN5uU8OUpYWIi3yGXleun7TGW1rpB9mWNPVaBrsjMVAnaWPa-_6ym2826ynTn-aQFvn6aIeB-wmumh6MwzY0DtsTK07-qAHg3YIR2Sv1V3A4589J09Xl4_L6-T2fnWzXNwmdZplQwIVA1blHHIhdVMLxrNSFAWilFIzIVqEgpdS8oy3qUw1okbOQELVCJSxxZycbXPjh-8jhkH1JtTYddqiG4PiwAsJooxt5wS20tq7EDy2auNNr_2kgKlvnGqLU0Wc6hunmqLn9Cd-rHps_hy__KKAbwUhnuwrevXmRm9j5X9SvwDnWIJN
CitedBy_id crossref_primary_10_1016_j_amjmed_2019_08_051
Cites_doi 10.1378/chest.11-2404
10.1378/chest.10-1944
10.1056/NEJM199909093411103
10.1002/14651858.CD008201.pub2
10.1160/TH14-03-0239
10.1111/j.1538-7836.2010.04044.x
10.1111/j.1572-0241.2008.02052.x
10.1378/chest.07-0430
10.1378/chest.11-2296
10.1038/ajg.2009.727
10.1378/chest.09-3081
10.1634/theoncologist.2015-0361
10.1007/s00228-005-0944-3
10.1200/JOP.2015.004473
10.1378/chest.11-2297
10.1002/14651858.CD003747.pub4
10.1160/TH05-06-0385
ContentType Journal Article
Copyright Springer Healthcare Ltd., part of Springer Nature 2018
Copyright_xml – notice: Springer Healthcare Ltd., part of Springer Nature 2018
DBID NPM
AAYXX
CITATION
7X8
DOI 10.1007/s12325-018-0821-y
DatabaseName PubMed
CrossRef
MEDLINE - Academic
DatabaseTitle PubMed
CrossRef
MEDLINE - Academic
DatabaseTitleList
MEDLINE - Academic
PubMed
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Pharmacy, Therapeutics, & Pharmacology
EISSN 1865-8652
EndPage 1883
ExternalDocumentID 10_1007_s12325_018_0821_y
30367365
Genre Journal Article
GroupedDBID ---
-5E
-5G
-BR
-EM
-Y2
-~C
.86
.VR
06C
06D
0R~
0VY
1N0
23M
2J2
2JN
2JY
2KG
2KM
2VQ
30V
4.4
406
408
40D
40E
53G
5GY
5VS
67Z
6NX
8TC
8UJ
95-
95.
95~
96X
AAAVM
AABHQ
AAIAL
AAIKX
AAJKR
AANXM
AANZL
AAPBV
AARHV
AARTL
AATNV
AAWCG
AAWTL
AAYFA
AAYIU
AAYQN
AAYTO
ABDZT
ABFTV
ABHLI
ABJNI
ABJOX
ABKCH
ABMNI
ABNWP
ABPLI
ABQBU
ABTKH
ABTMW
ABWBT
ABXPI
ACBMV
ACBRV
ACBYP
ACGFS
ACHXU
ACIGE
ACKNC
ACMLO
ACOKC
ACSNA
ACTTH
ACVWB
ADFZG
ADHHG
ADHIR
ADINQ
ADKPE
ADMDM
ADRFC
ADURQ
AEBTG
AEFTE
AEGAL
AEGNC
AEJHL
AEJRE
AEKMD
AENEX
AEOHA
AEPYU
AESKC
AETLH
AEVLU
AEXYK
AFALF
AFLOW
AFNRJ
AFWTZ
AFZKB
AGAYW
AGDGC
AGGBP
AGJBK
AGQMX
AGWIL
AGWZB
AGYKE
AHAVH
AHBYD
AHKMG
AHSBF
AHYZX
AIAKS
AIIXL
AILAN
AJBLW
AJDOV
AJRNO
ALMA_UNASSIGNED_HOLDINGS
ALWAN
AMKLP
AMXSW
AMYLF
AMYQR
ANMIH
ARMRJ
AWSVR
AXYYD
B-.
BA0
BGNMA
CAG
COF
CS3
CSCUP
DNIVK
DPUIP
EBD
EBLON
EBS
EIOEI
EJD
EMOBN
EN4
ESBYG
F5P
FERAY
FFXSO
FIGPU
FLLZZ
FNLPD
FRRFC
FSGXE
FWDCC
G-Y
G-Z
GGCAI
GGRSB
GJIRD
GNWQR
GQ6
GQ7
HF~
HG5
HG6
HMJXF
HRMNR
HZ~
IWAJR
IXC
IXD
I~X
I~Z
J-C
JBSCW
JZLTJ
KOV
KPH
LLZTM
M4Y
MA-
MK0
NQJWS
NU0
O9-
O93
O9I
OVD
P2P
P9S
PF0
QOR
QOS
R89
R9I
ROL
RPX
RSV
S16
S1Z
S27
S37
S3B
SAP
SDH
SHX
SISQX
SMD
SNE
SNPRN
SNX
SOHCF
SOJ
SPKJE
SRMVM
SSLCW
SV3
SZ9
SZN
T13
TEORI
TSG
TSK
TT1
TUC
U2A
U9L
UG4
UNUBA
UPIKM
UTJUX
UZXMN
VC2
VDBLX
VFIZW
W48
WK8
Z45
Z7U
Z7V
Z7W
Z81
Z82
Z83
Z84
Z87
~A9
~JE
AACDK
AASML
AAYZH
ABAKF
ACAOD
ACCOQ
ACDTI
ACZOJ
AEFQL
AEMSY
AFBBN
AGQEE
AGRTI
AIGIU
H13
NPM
SJYHP
ZMTXR
AAYXX
CITATION
7X8
ID FETCH-LOGICAL-c344t-1b010b521579adc70248766ee999a077fe162899242f393aeeae20191bd7e9303
IEDL.DBID AGYKE
ISSN 0741-238X
IngestDate Fri Oct 25 00:40:31 EDT 2024
Thu Sep 12 17:00:01 EDT 2024
Wed Oct 16 00:47:03 EDT 2024
Sat Dec 16 12:03:55 EST 2023
IsPeerReviewed true
IsScholarly true
Issue 11
Keywords Pulmonary embolism
Guideline adherence
Hospitalization
Preventive medicine
Cardiology
Heparin low-molecular-weight
Venous thromboembolism
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c344t-1b010b521579adc70248766ee999a077fe162899242f393aeeae20191bd7e9303
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ORCID 0000-0001-8407-6894
PMID 30367365
PQID 2126917867
PQPubID 23479
PageCount 11
ParticipantIDs proquest_miscellaneous_2126917867
crossref_primary_10_1007_s12325_018_0821_y
pubmed_primary_30367365
springer_journals_10_1007_s12325_018_0821_y
PublicationCentury 2000
PublicationDate 2018-11-01
PublicationDateYYYYMMDD 2018-11-01
PublicationDate_xml – month: 11
  year: 2018
  text: 2018-11-01
  day: 01
PublicationDecade 2010
PublicationPlace Cheshire
PublicationPlace_xml – name: Cheshire
– name: United States
PublicationTitle Advances in therapy
PublicationTitleAbbrev Adv Ther
PublicationTitleAlternate Adv Ther
PublicationYear 2018
Publisher Springer Healthcare
Publisher_xml – name: Springer Healthcare
References Falck-Ytter, Francis, Johanson (CR12) 2012; 141
Kuderer, Culakova, Lyman, Francis, Falanga, Khorana (CR8) 2016; 21
Alikhan, Forster, Cohen (CR26) 2014
Gould, Garcia, Wren (CR13) 2012; 141
Mahé, Bergmann, d’Azémar, Vaissie, Caulin (CR24) 2005; 61
CR17
CR14
CR11
CR10
Kornbluth, Sachar (CR16) 2010; 105
Cohen, Alikhan, Arcelus (CR1) 2005; 94
Mahan, Liu, Turpie (CR7) 2014; 112
Decousus, Tapson, Bergmann (CR9) 2011; 139
Bergmann, Lloret-Linares, Rami (CR2) 1983; 2011
CR4
Lyman, Bohlke, Falanga (CR18) 2015; 11
CR6
Spyropoulos, Anderson, FitzGerald (CR5) 2011; 140
Sabroe (CR3) 2016; 178
Kahn, Lim, Dunn (CR20) 2012; 141
CR23
CR22
Barbar, Noventa, Rossetto (CR21) 2010; 8
Samama, Cohen, Darmon (CR25) 1999; 341
Kahn, Morrison, Cohen, Emed, Tagalakis, Roussin, Geerts (CR27) 2013
Piazza, Seddighzadeh, Goldhaber (CR19) 2007; 132
Nguyen, Sam (CR15) 2008; 103
AT Cohen (821_CR1) 2005; 94
821_CR22
MM Samama (821_CR25) 1999; 341
821_CR23
JE Sabroe (821_CR3) 2016; 178
NM Kuderer (821_CR8) 2016; 21
821_CR4
AC Spyropoulos (821_CR5) 2011; 140
821_CR6
S Barbar (821_CR21) 2010; 8
CE Mahan (821_CR7) 2014; 112
MK Gould (821_CR13) 2012; 141
GC Nguyen (821_CR15) 2008; 103
J-F Bergmann (821_CR2) 1983; 2011
Y Falck-Ytter (821_CR12) 2012; 141
821_CR11
821_CR10
GH Lyman (821_CR18) 2015; 11
G Piazza (821_CR19) 2007; 132
821_CR14
821_CR17
I Mahé (821_CR24) 2005; 61
A Kornbluth (821_CR16) 2010; 105
SR Kahn (821_CR27) 2013
R Alikhan (821_CR26) 2014
H Decousus (821_CR9) 2011; 139
SR Kahn (821_CR20) 2012; 141
References_xml – ident: CR22
– volume: 141
  start-page: e278S
  year: 2012
  end-page: e325S
  ident: CR12
  article-title: Prevention of VTE in orthopedic surgery patients: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines
  publication-title: Chest
  doi: 10.1378/chest.11-2404
  contributor:
    fullname: Johanson
– volume: 140
  start-page: 706
  year: 2011
  end-page: 714
  ident: CR5
  article-title: Predictive and associative models to identify hospitalized medical patients at risk for VTE
  publication-title: Chest
  doi: 10.1378/chest.10-1944
  contributor:
    fullname: FitzGerald
– ident: CR4
– ident: CR14
– volume: 2011
  start-page: e528
  issue: 40
  year: 1983
  end-page: e537
  ident: CR2
  article-title: Venous thromboembolism risk and prophylaxis in the acute hospital care setting (ENDORSE study): results obtained in France
  publication-title: Presse Med Paris Fr
  contributor:
    fullname: Rami
– volume: 341
  start-page: 793
  year: 1999
  end-page: 800
  ident: CR25
  article-title: A comparison of enoxaparin with placebo for the prevention of venous thromboembolism in acutely ill medical patients prophylaxis in medical patients with Enoxaparin Study Group
  publication-title: N Engl J Med
  doi: 10.1056/NEJM199909093411103
  contributor:
    fullname: Darmon
– ident: CR10
– year: 2013
  ident: CR27
  article-title: Interventions for implementation of thromboprophylaxis in hospitalized medical and surgical patients at risk for venous thromboembolism
  publication-title: Cochrane Database Syst Rev.
  doi: 10.1002/14651858.CD008201.pub2
  contributor:
    fullname: Geerts
– ident: CR6
– volume: 112
  start-page: 692
  year: 2014
  end-page: 699
  ident: CR7
  article-title: External validation of a risk assessment model for venous thromboembolism in the hospitalised acutely-ill medical patient (VTE-VALOURR)
  publication-title: Thromb Haemost
  doi: 10.1160/TH14-03-0239
  contributor:
    fullname: Turpie
– volume: 8
  start-page: 2450
  year: 2010
  end-page: 2457
  ident: CR21
  article-title: A risk assessment model for the identification of hospitalized medical patients at risk for venous thromboembolism: the Padua Prediction Score
  publication-title: J Thromb Haemost JTH
  doi: 10.1111/j.1538-7836.2010.04044.x
  contributor:
    fullname: Rossetto
– volume: 103
  start-page: 2272
  year: 2008
  end-page: 2280
  ident: CR15
  article-title: Rising prevalence of venous thromboembolism and its impact on mortality among hospitalized inflammatory bowel disease patients
  publication-title: Am J Gastroenterol
  doi: 10.1111/j.1572-0241.2008.02052.x
  contributor:
    fullname: Sam
– ident: CR23
– volume: 132
  start-page: 554
  year: 2007
  end-page: 561
  ident: CR19
  article-title: Double trouble for 2,609 hospitalized medical patients who developed deep vein thrombosis: prophylaxis omitted more often and pulmonary embolism more frequent
  publication-title: Chest
  doi: 10.1378/chest.07-0430
  contributor:
    fullname: Goldhaber
– volume: 141
  start-page: e195S
  year: 2012
  end-page: e226S
  ident: CR20
  article-title: Prevention of VTE in Nonsurgical Patients
  publication-title: Chest
  doi: 10.1378/chest.11-2296
  contributor:
    fullname: Dunn
– volume: 105
  start-page: 501
  year: 2010
  end-page: 523
  ident: CR16
  article-title: Practice Parameters Committee of the American College of Gastroenterology. Ulcerative colitis practice guidelines in adults: American College Of Gastroenterology, Practice Parameters Committee
  publication-title: Am J Gastroenterol
  doi: 10.1038/ajg.2009.727
  contributor:
    fullname: Sachar
– volume: 94
  start-page: 750
  year: 2005
  end-page: 759
  ident: CR1
  article-title: Assessment of venous thromboembolism risk and the benefits of thromboprophylaxis in medical patients
  publication-title: Thromb Haemost
  contributor:
    fullname: Arcelus
– volume: 139
  start-page: 69
  year: 2011
  end-page: 79
  ident: CR9
  article-title: Factors at admission associated with bleeding risk in medical patients: findings from the IMPROVE investigators
  publication-title: Chest
  doi: 10.1378/chest.09-3081
  contributor:
    fullname: Bergmann
– ident: CR17
– volume: 178
  start-page: 2
  year: 2016
  end-page: 5
  ident: CR3
  article-title: Madsen SM [Low molecular weight heparin as venous thromboembolism prophylaxis in hospitalized medical patients]
  publication-title: Ugeskr Laeger
  contributor:
    fullname: Sabroe
– volume: 21
  start-page: 861
  year: 2016
  end-page: 867
  ident: CR8
  article-title: A validated risk score for venous thromboembolism is predictive of cancer progression and mortality
  publication-title: Oncologist
  doi: 10.1634/theoncologist.2015-0361
  contributor:
    fullname: Khorana
– ident: CR11
– volume: 61
  start-page: 347
  year: 2005
  end-page: 351
  ident: CR24
  article-title: Lack of effect of a low-molecular-weight heparin (nadroparin) on mortality in bedridden medical in-patients: a prospective randomised double-blind study
  publication-title: Eur J Clin Pharmacol
  doi: 10.1007/s00228-005-0944-3
  contributor:
    fullname: Caulin
– volume: 11
  start-page: e442
  year: 2015
  end-page: e444
  ident: CR18
  article-title: Venous thromboembolism prophylaxis and treatment in patients with cancer: American Society of Clinical Oncology clinical practice guideline update
  publication-title: J Oncol Pract
  doi: 10.1200/JOP.2015.004473
  contributor:
    fullname: Falanga
– volume: 141
  start-page: e227S
  year: 2012
  end-page: e277S
  ident: CR13
  article-title: Prevention of VTE in nonorthopedic surgical patients: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines
  publication-title: Chest
  doi: 10.1378/chest.11-2297
  contributor:
    fullname: Wren
– year: 2014
  ident: CR26
  article-title: Heparin for the prevention of venous thromboembolism in acutely ill medical patients (excluding stroke and myocardial infarction)
  publication-title: Cochrane Database Syst Rev.
  doi: 10.1002/14651858.CD003747.pub4
  contributor:
    fullname: Cohen
– volume: 132
  start-page: 554
  year: 2007
  ident: 821_CR19
  publication-title: Chest
  doi: 10.1378/chest.07-0430
  contributor:
    fullname: G Piazza
– volume: 11
  start-page: e442
  year: 2015
  ident: 821_CR18
  publication-title: J Oncol Pract
  doi: 10.1200/JOP.2015.004473
  contributor:
    fullname: GH Lyman
– volume: 139
  start-page: 69
  year: 2011
  ident: 821_CR9
  publication-title: Chest
  doi: 10.1378/chest.09-3081
  contributor:
    fullname: H Decousus
– volume: 140
  start-page: 706
  year: 2011
  ident: 821_CR5
  publication-title: Chest
  doi: 10.1378/chest.10-1944
  contributor:
    fullname: AC Spyropoulos
– year: 2014
  ident: 821_CR26
  publication-title: Cochrane Database Syst Rev.
  doi: 10.1002/14651858.CD003747.pub4
  contributor:
    fullname: R Alikhan
– volume: 141
  start-page: e227S
  year: 2012
  ident: 821_CR13
  publication-title: Chest
  doi: 10.1378/chest.11-2297
  contributor:
    fullname: MK Gould
– ident: 821_CR22
– volume: 94
  start-page: 750
  year: 2005
  ident: 821_CR1
  publication-title: Thromb Haemost
  doi: 10.1160/TH05-06-0385
  contributor:
    fullname: AT Cohen
– volume: 21
  start-page: 861
  year: 2016
  ident: 821_CR8
  publication-title: Oncologist
  doi: 10.1634/theoncologist.2015-0361
  contributor:
    fullname: NM Kuderer
– ident: 821_CR10
– volume: 112
  start-page: 692
  year: 2014
  ident: 821_CR7
  publication-title: Thromb Haemost
  doi: 10.1160/TH14-03-0239
  contributor:
    fullname: CE Mahan
– ident: 821_CR14
– volume: 141
  start-page: e278S
  year: 2012
  ident: 821_CR12
  publication-title: Chest
  doi: 10.1378/chest.11-2404
  contributor:
    fullname: Y Falck-Ytter
– ident: 821_CR23
– volume: 2011
  start-page: e528
  issue: 40
  year: 1983
  ident: 821_CR2
  publication-title: Presse Med Paris Fr
  contributor:
    fullname: J-F Bergmann
– volume: 8
  start-page: 2450
  year: 2010
  ident: 821_CR21
  publication-title: J Thromb Haemost JTH
  doi: 10.1111/j.1538-7836.2010.04044.x
  contributor:
    fullname: S Barbar
– volume: 341
  start-page: 793
  year: 1999
  ident: 821_CR25
  publication-title: N Engl J Med
  doi: 10.1056/NEJM199909093411103
  contributor:
    fullname: MM Samama
– year: 2013
  ident: 821_CR27
  publication-title: Cochrane Database Syst Rev.
  doi: 10.1002/14651858.CD008201.pub2
  contributor:
    fullname: SR Kahn
– volume: 178
  start-page: 2
  year: 2016
  ident: 821_CR3
  publication-title: Ugeskr Laeger
  contributor:
    fullname: JE Sabroe
– ident: 821_CR4
– ident: 821_CR6
– volume: 61
  start-page: 347
  year: 2005
  ident: 821_CR24
  publication-title: Eur J Clin Pharmacol
  doi: 10.1007/s00228-005-0944-3
  contributor:
    fullname: I Mahé
– volume: 141
  start-page: e195S
  year: 2012
  ident: 821_CR20
  publication-title: Chest
  doi: 10.1378/chest.11-2296
  contributor:
    fullname: SR Kahn
– volume: 105
  start-page: 501
  year: 2010
  ident: 821_CR16
  publication-title: Am J Gastroenterol
  doi: 10.1038/ajg.2009.727
  contributor:
    fullname: A Kornbluth
– ident: 821_CR11
– ident: 821_CR17
– volume: 103
  start-page: 2272
  year: 2008
  ident: 821_CR15
  publication-title: Am J Gastroenterol
  doi: 10.1111/j.1572-0241.2008.02052.x
  contributor:
    fullname: GC Nguyen
SSID ssj0020758
Score 2.2162468
Snippet Introduction The risk of venous thromboembolism (VTE) is increased by more than 100-fold among hospitalised medical patients compared to subjects in the...
The risk of venous thromboembolism (VTE) is increased by more than 100-fold among hospitalised medical patients compared to subjects in the community. The...
INTRODUCTIONThe risk of venous thromboembolism (VTE) is increased by more than 100-fold among hospitalised medical patients compared to subjects in the...
SourceID proquest
crossref
pubmed
springer
SourceType Aggregation Database
Index Database
Publisher
StartPage 1873
SubjectTerms Cardiology
Endocrinology
Internal Medicine
Medicine
Medicine & Public Health
Oncology
Original Research
Pharmacology/Toxicology
Rheumatology
Title Compliance with Guidelines on Thromboprophylaxis for Acutely Admitted Medical Patients
URI https://link.springer.com/article/10.1007/s12325-018-0821-y
https://www.ncbi.nlm.nih.gov/pubmed/30367365
https://search.proquest.com/docview/2126917867
Volume 35
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1La9wwEB7ygNJL2qav7WNRoeTQRktly5J93IRsQkvCHrJlezKSM4KQ1A6xDXV_fUd-7FK2PeRuS7Zm5O8bzcxngI9Wi8A56bjTgeMSEbl1seIuDIQTkQ1Mq8R0fqHOFvLrMlpuQbA6ushvJkNGsv1Qr3vdCPt9nZkXVA4Eb7Zht-873Z2e_vh2sgqzCATjTnxTcAKk5ZDL_Ncgf6PRBsXcSI-2qDN70nUClq1YoS82uZnUlZ1kvzelHB_wQk9hryehbNp5zTPYwnwfHp33afZ9OJh3gtbNIbtc92eVh-yAzddS181z-H7cVqR7z2H-RJed1l42y5fSsyKnm--Ln7agpydj3ppf1yUjjsymWV3hbcO8cG9FjJf12SI270ReyxewmJ1cHp_x_k8NPAulrLiwFNZZMkekE3OVaS-UppVCJPppvmjtUCgf2REfcGESGkSDxDwSYa80JoSiL2EnL3J8DSxGYW0sncpkKDMnLDojEyfRCNRZFI_g02Cx9K4T5EjX0st-SVNa0tQvadqM4MNg05S2jc-FmByLukzJcxRFqrHSI3jVGXs1nEd1HapoBJ8Hy6X9zi7_P9ebB139Fh4H3vRtV-M72Knua3xP9KayY_Ln2dHRxbj36zFsL4LpH0T09Hc
link.rule.ids 315,783,787,27936,27937,41093,41535,42162,42604,52123,52246
linkProvider Springer Nature
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Nb9QwEB3BVoJeKBQoSwsYCfUATYUTx06Oq6rtQrvVHrZoOVl2OpYQJUFNIhF-PeN8dFUKh94T2_GM895kZl4A3lnFQ-eEC5wKXSAQMbAukYGLQu54bEPTKjHNzuT0XHxexsu-j7scqt2HlGT7pl41uxH4-0Izr6gc8qC5D2si5DIcwdrk-OvJ4XWcRSiYdOqbPCBEWg7JzH8NchOObnHMW_nRFnaONmAxLLirNvm-X1d2P_v9l5bjHZ_oMTzqaSibdH7zBO5hvgkPZn2ifRN2552kdbPHFqsOrXKP7bL5Suy6eQpfDtqadO87zH_TZce1F87yxfSsyOnmq-KHLWj5ZM5L8-tbyYgls0lWV3jZMC_dWxHnZX2-iM07mdfyGZwfHS4OpkH_r4Ygi4SoAm4psLPEBWKVmotMeak0JSUiEVDzUSmHZCmK7YgRuCiNDKJB4h4ptxcKU8LR5zDKixxfAEuQW5sIJzMRicxxi86I1Ak0HFUWJ2N4P5hM_-wkOfRKfNlvqaYt1X5LdTOGt4NRNR0cnw0xORZ1qQmzJcWqiVRj2OqsfT2cx3UVyXgMHwbL6f5sl_-f6-Wdrn4DD6eL2ak-_XR2sg3roXeDtsdxB0bVVY2viOxU9nXv3H8APQn15g
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9QwEB7BVqq48Civ5Wkk1APULU4cOzmuSreF0moPLVpOxs6OJURJqiaRCL-e8SbpCgoHxD2xY89Y3zeZmc8AL50WkffSc68jzyUicudTxX0cCS8SF9mlEtPRsTo4le_nyby_57Qaqt2HlGTX0xBUmop653zhd1aNb0QEQtFZUFeOBG-vw5oMwkgjWJvsfzrcu4y5CBHTTolTcEKn-ZDY_NMgv0LTFb55JVe6hKDpLfg8fHxXefJ1u6nddv7jN13H_1jdbbjZ01M26fzpDlzDYgPWj_oE_AZszjqp63aLnaw6t6ottslmKxHs9i583F3WqgefYuFfL9tvgqBWKLJnZUEvX5TfXElLITOf2e9fKkbsmU3ypsazlgVJ35q4MOvzSGzWyb9W9-B0uneye8D7Oxx4HktZc-Eo4HPEERKd2UWug4SaVgqRiKl9o7VHoULMR0zBx1lsES0SJ8mEW2jMCF_vw6goC3wILEXhXCq9ymUscy8ceiszL9EK1HmSjuHVYD5z3kl1mJUoc9hSQ1tqwpaadgwvBgMbOlAhS2ILLJvKEJYrimFTpcfwoLP85XAB73WskjG8Hqxo-jNf_X2uR__09HNYn72dmg_vjg8fw40oeMGy9fEJjOqLBp8SB6rds97PfwKUy_7K
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Compliance+with+Guidelines+on+Thromboprophylaxis+for+Acutely+Admitted+Medical+Patients&rft.jtitle=Advances+in+therapy&rft.au=Freund%2C+Nanna&rft.au=Sabroe%2C+Jonas+E&rft.au=Bytzer%2C+Peter&rft.au=Madsen%2C+S%C3%B8ren+M&rft.date=2018-11-01&rft.eissn=1865-8652&rft.volume=35&rft.issue=11&rft.spage=1873&rft_id=info:doi/10.1007%2Fs12325-018-0821-y&rft_id=info%3Apmid%2F30367365&rft.externalDocID=30367365
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0741-238X&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0741-238X&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0741-238X&client=summon